Clinical study pediatric gerd aciphex

Aciphex - FDA prescribing information, side effects and

Aciphex delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD).

Pediatric GERD Medicine

Choosing to participate in a study is an important personal decision.

<em>Clinical</em> trial A <em>Study</em> of Single and Multiple Doses of

Clinical trial A Study of Single and Multiple Doses of

The American Academy of Pediatrics (AAP) has published a guideline on the management of gastroesophageal reflux (GER) in children based on recommendations from the North American and European Societies for Pediatric Gastroenterology, Hepatology, and Nutrition.

NEW DRUG APPLICATION FOR PEDIATRIC FORMULATION.

FULL PRESCRIBING INFORMATION ACIPHEX is indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD).


Clinical study pediatric gerd aciphex:

Rating: 94 / 100

Overall: 89 Rates